Volume 10, Number 11, November 2004

Histopathologic Improvement with Lymphedema Management, Léogâne, Haiti

Susan F. Wilson,* Jeannette Guarner,* Alix L. Valme,† Jacky Louis-Charles,† Tara L. Jones,* and David G. Addiss*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and †Hôpital Ste. Croix, Léogâne, Haiti

Figure 2. Individual histologic responses of the 27 patients with follow-up biopsy specimens who participated in a lymphedema management program for ≈1 year. Black boxes indicate histopathologic regression or improvement, gray boxes indicate histopathologic progression or worsening, white boxes indicate the absence of histopathologic changes in either biopsy specimens, and boxes with a diagonal line indicate that histopathologic changes were observed on both initial and follow-up biopsy specimens. Boxes with an X indicate insufficient data.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed October 15, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention